{
  "trial_id": "NCT04055090",
  "trial_group": "diabetes",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, duration of diabetes, baseline pain score, HbA1c levels, body mass index (BMI), use of pain medications, history of diabetic complications, baseline neuropathy score, baseline quality of life score.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Body Mass Index",
          "body mass index (BMI)"
        ],
        [
          "HB1Ac",
          "HbA1c levels"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Race (NIH/OMB)",
        "Region of Enrollment",
        "Gabapentin and/or Pregabalin Use",
        "Diabetes Type"
      ],
      "remaining_candidate_features": [
        "duration of diabetes",
        "baseline pain score",
        "use of pain medications",
        "history of diabetic complications",
        "baseline neuropathy score",
        "baseline quality of life score"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetes, Baseline Pain Score, Concomitant Medications, Baseline Neuropathy Score, Baseline HbA1c, ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Body Mass Index",
          "Baseline HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Race (NIH/OMB)",
        "Gabapentin and/or Pregabalin Use",
        "Diabetes Type",
        "HB1Ac"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Duration of Diabetes",
        "Baseline Pain Score",
        "Concomitant Medications",
        "Baseline Neuropathy Score"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Duration of Diabetic Neuropathy, Baseline Pain Score, HbA1c, BMI, Diabetes Duration,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Body Mass Index",
          "BMI"
        ],
        [
          "HB1Ac",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Race (NIH/OMB)",
        "Gabapentin and/or Pregabalin Use",
        "Diabetes Type"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Duration of Diabetic Neuropathy",
        "Baseline Pain Score",
        "Diabetes Duration"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, body mass index (BMI), duration of diabetes, duration of painful diabetic neuropathy, HbA1c, fasting blood glucose, blood pressure, history of smoking, concomitant medications, prior pain treatments, pain severity at baseline (e.g., using a pain scale such as the Brief Pain Inventory), quality of life measures (e.g., SF-36), and presence of comorbidities (e.g., hypertension, hyperlipidemia).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "Body Mass Index",
          "body mass index (BMI)"
        ],
        [
          "HB1Ac",
          "HbA1c"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment",
        "Gabapentin and/or Pregabalin Use",
        "Diabetes Type"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "duration of diabetes",
        "duration of painful diabetic neuropathy",
        "fasting blood glucose",
        "blood pressure",
        "history of smoking",
        "concomitant medications",
        "prior pain treatments",
        "pain severity at baseline (e.g., using a pain scale such as the Brief Pain Inventory)",
        "quality of life measures (e.g., SF-36)",
        "presence of comorbidities (e.g., hypertension, hyperlipidemia)"
      ]
    }
  }
}